Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Axsome Therapeutics, Inc. (AXSM)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-05-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   8-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]58.10.00.00.00.00.00.00.0
Cost of goods sold  58.10.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.00.00.0
            Gross margin  0.0%       
Selling, general and administrative   [+]66.6124.799.167.29.47.26.32.4
Research and development      23.520.021.26.8
Other operating expenses  53.9-124.7-99.1-67.2   0.2
EBITDA   [+]    -32.8-27.1-27.5-9.4
            EBITDA margin  -214.8%       
Depreciation and amortization      0.00.00.00.0
EBIT   [+]-124.70.00.00.0-32.8-27.2-27.5-9.4
            EBIT margin  -214.8%       
Non-recurring items         -0.2
Interest income, net   [+]-5.7-5.7-2.6-1.21.11.30.10.7
Other income (expense), net   [+] -124.7-100.3-67.10.8-3.10.2-3.8
Pre-tax income  -130.4-130.4-102.9-68.3-31.0-28.9-27.2-12.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -130.4-130.4-102.9-68.3-31.0-28.9-27.2-12.2
            Net margin  -224.6%       
   
Basic EPS   [+]($3.47)($3.47)($2.77)($2.01)($1.15)($1.27)($1.42)($1.02)
Diluted EPS   [+]($3.47)($3.47)($2.77)($2.01)($1.15)($1.27)($1.42)($1.02)
   
Shares outstanding (basic)   [+]37.637.637.234.026.922.819.211.9
Shares outstanding (diluted)   [+]37.637.637.234.026.922.819.211.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy